中文 | English     

B-hTNFRSF4(OX40) mice (TNFRSF4(OX40) humanized mice)

2017-05-09 17:41:18.0

Basic characteristics:


OX40 (Tumor necrosis factor receptor superfamily, member 4, also known as Tnfrsf4), is mainly expressed on the surface of activated CD4+ and CD8+ T cells, and its binding to the OX40L ligand stimulates CD8+ T cell activation. Coactivation of OX40/OX40L enhances T cell functions, including cytokine production, proliferation and survival. OX40 agonistsreduce Regulatory T cells (Tregs) and improve anti-tumor activity.


Targeting strategy:



图片.png


mRNA expression verification:

图片.png

Fig 1. Molecular identification of the B-hOX40 humanized mice. Mouse OX-40 mRNA was detected in both the wild type and the B-hOX40 heterozygous mice, while human OX40 mRNA was detected only in theB-hOX40 heterozygous mice.


Protein expression verification:

图片.png

Fig 2. Spleen cells from both wild type (WT) C57BL/6 and the B-hOX40 homozygous mice were analyzed by flow cytometry. Mouse OX40+ T cells were detected in the WT mice, while human OX40+ T cells were detected in the B-hOX40 homozygous mice.


OX40 antibody pharmacological verification:

图片.png

Fig 3. Murine colon tumor MC38 cells were subcutaneously injected into B-hOX40 heterozygous mice, which were grouped when the tumor size reached 100 mm3 (n=5). The human OX40 antibody significantly inhibited tumor growth (A), but not body weight (B) at 3 different doses. B-hOX40 mice are powerful tools for human OX40 antibody in vivo pharmacological efficacy test.

Copyright © BIOCYTOGEN LLC. 2017 All Rights Reserved.